GEODE CAPITAL MANAGEMENT, LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2023$370,683
-55.6%
790,167
+4.0%
0.00%
Q2 2023$835,607
+11.9%
759,643
+21.1%
0.00%
Q1 2023$746,423
+131081.5%
627,247
+64.1%
0.00%
Q4 2022$569
-99.9%
382,339
+2.4%
0.00%
Q3 2022$608,000
+106.8%
373,304
+0.7%
0.00%
Q2 2022$294,000
-56.1%
370,529
-0.4%
0.00%
Q1 2022$669,000
+11.3%
372,005
+5.7%
0.00%
Q4 2021$601,000
-15.7%
351,786
+1.6%
0.00%
Q3 2021$713,000
+0.8%
346,208
+13.0%
0.00%
Q2 2021$707,000
-28.1%
306,269
-13.1%
0.00%
Q1 2021$983,000
+32.1%
352,367
+34.9%
0.00%
Q4 2020$744,000
+31.7%
261,292
-2.9%
0.00%
Q3 2020$565,000
-54.1%
269,157
-0.6%
0.00%
Q2 2020$1,232,000
-48.4%
270,820
-7.3%
0.00%
-100.0%
Q1 2020$2,387,000
-77.3%
292,187
-49.0%
0.00%0.0%
Q4 2019$10,502,000
+212.7%
572,988
+89.0%
0.00%0.0%
Q3 2019$3,358,000
+3.1%
303,155
-5.4%
0.00%0.0%
Q2 2019$3,258,000
+179.2%
320,425
+60.9%
0.00%
Q1 2019$1,167,000
-47.9%
199,155
-37.0%
0.00%
Q4 2018$2,242,000
+124.2%
315,906
+124.6%
0.00%
Q3 2018$1,000,000
+49.5%
140,654
+5.4%
0.00%
Q2 2018$669,000
-49.0%
133,416
+11.9%
0.00%
Q1 2018$1,312,000
+23.8%
119,233
+4.0%
0.00%
Q4 2017$1,060,000
+2.4%
114,667
-0.6%
0.00%
Q3 2017$1,035,000
+29.4%
115,358
+1.3%
0.00%
Q2 2017$800,000
+3.1%
113,859
+28.1%
0.00%
Q1 2017$776,000
+44.8%
88,853
+33.5%
0.00%
Q4 2016$536,000
+135.1%
66,565
+158.0%
0.00%
Q3 2016$228,000
+11.8%
25,801
+0.1%
0.00%
Q2 2016$204,000
+33.3%
25,7750.0%0.00%
Q1 2016$153,000
-34.1%
25,775
-0.1%
0.00%
Q4 2015$232,000
-24.9%
25,801
+0.2%
0.00%
Q3 2015$309,000
+19.8%
25,749
+28.8%
0.00%
Q2 2015$258,000
+94.0%
19,984
+36.1%
0.00%
Q1 2015$133,000
+224.4%
14,6840.0%0.00%
Q4 2014$41,000
-4.7%
14,6840.0%0.00%
Q3 2014$43,000
-63.2%
14,6840.0%0.00%
Q2 2014$117,00014,6840.00%
Other shareholders
RECRO PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders